Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions		Sep. 30, 2024	Dec. 31, 2023
Assets
Cash and cash equivalents		$ 648	$ 400
Restricted cash and cash equivalents (Note 16)		484	501
Accounts receivable (Note 4)		97	137
Inventory, net (Note 6)		297	375
Derivative instruments (Notes 3 and 12)		50	89
Other current assets		97	52
Total current assets		1,673	1,554
Property, plant and equipment, net (Note 8)		3,228	3,839
Nuclear decommissioning trust funds (Notes 7 and 12)		1,737	1,575
Derivative instruments (Notes 3 and 12)		22	6
Other noncurrent assets		188	147
Total Assets		6,848	7,121
Liabilities and Equity
Long-term debt, due within one year (Notes 11 and 12)		9	9
Accrued interest		54	32
Accounts payable and other accrued liabilities		210	344
Derivative instruments (Notes 3 and 12)		6	32
Other current liabilities		129	69
Total current liabilities		408	486
Long-term debt (Notes 11 and 12)		2,616	2,811
Derivative instruments (Notes 3 and 12)		4	11
Postretirement benefit obligations (Note 13)		318	368
Asset retirement obligations and accrued environmental costs (Note 9)		475	469
Deferred income taxes (Note 5)		452	407
Other noncurrent liabilities		130	35
Total Liabilities		4,403	4,587
Commitments and Contingencies (Note 10)
Stockholders’ Equity
Common stock ($0.001 par value 350,000,000 shares authorized)	[1],[2]	0	0
Additional paid-in capital		1,980	2,346
Accumulated retained earnings (deficit)		412	134
Accumulated other comprehensive income (loss)		(5)	(23)
Total Stockholders’ Equity		2,387	2,457
Noncontrolling interests		58	77
Total Equity		2,445	2,534
Total Liabilities and Equity		$ 6,848	$ 7,121

[1] As of December 31, 2023 (Successor): 59,028,843 shares issued and outstanding.

[2] As of September 30, 2024 (Successor): 50,855,417 shares issued and outstanding,